UBS Group’s Histogen Inc. Common Stock HSTO Stock Holding History

UBS Group’s Portfolio HSTO Stock Details HSTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-5	Closed	-$5K	–	8744
2015 Q2	$5K	Sell	5 -10	-67%	-$11.7K	﹤0.01%	7898
2015 Q1	$21K	Buy	+15	New	+$19K	﹤0.01%	6956

Other funds holding HSTO

HCM

Highlander Capital Management Short Hills, New Jersey $292M AUM 22.24% 1-Year Est. Return

UBS Group's HSTO Position: Q4 2023 in Review

UBS Group sold out of Histogen Inc. Common Stock (HSTO) in Q4 2023, closing a stake of 89 shares — an estimated $46 sold.

UBS Group first reported a position in HSTO in Q4 2014 and held it in 27 quarters. The position peaked at $51K in Q3 2018. 1 fund tracked by Wall St. Rank holds HSTO as of Q4 2023.

UBS Group reported no remaining Histogen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
UBS Group sold 89 Histogen Inc. Common Stock shares in Q4 2023, an estimated $46.
UBS Group first reported a position in Histogen Inc. Common Stock in Q4 2014 and held it in 27 quarters.
UBS Group's Histogen Inc. Common Stock position peaked at $51K in Q3 2018.
1 fund tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2023.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.